Description |
1 online resource (xxvi, 491 pages) |
Contents |
Product suppliers in the healthcare value chain / Lawton R. Burns -- The pharmaceutical sector / Richard T. Evans, Scott Hinds -- The biotechnology sector : therapeutics / Cary G. Pfeffer -- New Venture Creation in Biotechnology / Jason Rhodes, Lawton Robert Burns -- The medical device sector / Kurt H. Kruger, Max A. Kruger -- Financing medtech innovation / Justin Klein -- The healthcare information technology sector / Adam C. Powell, John Glaser |
Summary |
"Perhaps as never before, countries around the world are looking at biomedical innovation as a source of (a) knowledge creation by their scientific communities, (b) value creation for their populations, and (c) wealth creation by fostering industries and expansion of employment. In the U.S., for example, bipartisan passage of the 21st Century Cures Act of 2016 seeks to accelerate new product development and faster patient access to new treatments and therapies. It also elevates the role of biomedical research through an additional $6.3 billion in funding for the National Institutes of Health (NIH) and other agencies"-- Provided by publisher |
Bibliography |
Includes bibliographical references and index |
Notes |
Description based on online resource; title from digital title page (viewed on April 20, 2020) |
Subject |
Medical care -- Technological innovations
|
|
Medical technology -- Economic aspects
|
|
Business forecasting.
|
|
Economic forecasting.
|
|
Business forecasting
|
|
Economic forecasting
|
|
Medical care -- Technological innovations
|
|
Medical technology -- Economic aspects
|
Form |
Electronic book
|
Author |
Burns, Lawton R., editor.
|
LC no. |
2019039715 |
ISBN |
9781108785549 |
|
1108785549 |
|